Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging

MIRAMAR, Fla., May 12, 2025 -- Kimera Labs, Inc., the pioneer in therapeutic exosome biotechnology, is proud to announce its selection as a semifinalist in the prestigious $101 million XPRIZE Healthspan competition. This milestone recognizes Kimera's groundbreaking work in developing cutting-edge exosome-based therapeutics aimed at significantly extending the healthy, active years of human life.

Exhibitor Data Sheet